These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26862208)

  • 21. Posttranslational modifications as versatile regulators of parkin function.
    Rubio de la Torre E; Gómez-Suaga P; Martínez-Salvador M; Hilfiker S
    Curr Med Chem; 2011; 18(16):2477-85. PubMed ID: 21568911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modes of allosteric regulation of the ubiquitination machinery.
    Rennie ML; Chaugule VK; Walden H
    Curr Opin Struct Biol; 2020 Jun; 62():189-196. PubMed ID: 32305021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling through monoubiquitination.
    Sigismund S; Polo S; Di Fiore PP
    Curr Top Microbiol Immunol; 2004; 286():149-85. PubMed ID: 15645713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
    Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
    Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ubiquitin-protein ligases Nedd4 and Nedd4-2 show similar ubiquitin-conjugating enzyme specificities.
    Fotia AB; Cook DI; Kumar S
    Int J Biochem Cell Biol; 2006 Mar; 38(3):472-9. PubMed ID: 16337426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro protein ubiquitination assay.
    Zhao Q; Liu L; Xie Q
    Methods Mol Biol; 2012; 876():163-72. PubMed ID: 22576094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
    Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
    Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of ubiquitination dependent dynamics in growth factor receptor signaling by quantitative proteomics.
    Akimov V; Rigbolt KT; Nielsen MM; Blagoev B
    Mol Biosyst; 2011 Dec; 7(12):3223-33. PubMed ID: 21956701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkin and relatives: the RBR family of ubiquitin ligases.
    Marín I; Lucas JI; Gradilla AC; Ferrús A
    Physiol Genomics; 2004 May; 17(3):253-63. PubMed ID: 15152079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin and SUMO signalling in DNA repair.
    Thomson TM; Guerra-Rebollo M
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):116-31. PubMed ID: 20074046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
    Durcan TM; Fon EA
    Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkin genetics: one model for Parkinson's disease.
    Mata IF; Lockhart PJ; Farrer MJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R127-33. PubMed ID: 14976155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkin structure and function.
    Seirafi M; Kozlov G; Gehring K
    FEBS J; 2015 Jun; 282(11):2076-88. PubMed ID: 25712550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting neddylation in cancer therapy.
    Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
    Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.